Pharmacotherapeutics for Advanced Practice Nurse Prescribers

by Woo, Teri Moser; Wright, Wendy L.

• ISBN13: 9781719648035
• ISBN10: 1719648034
• eBook ISBN(s): 9781719651585
• Additional ISBN(s): 9780803638273, 9780803669260
• Edition: 6th
• Format: Hardcover w/ Access Code
• Copyright: 2024-04-16
• Publisher: F.A. Davis Company
• More Book Details

About This Book

Pharmacotherapeutics for Advanced Practice Nurse Prescribers

ISBN: 9781719648035

Pharmacotherapeutics for Advanced Practice Nurse Prescribers is a comprehensive textbook designed specifically for advanced practice nurse prescribers. This 6th edition, published by F.A. Davis Company, is a go-to resource for students and educators alike, offering a detailed exploration of pharmacologic principles and their applications in clinical practice.

Who Uses It?

Primarily, this book is used by advanced practice nurse prescribers, including nurse practitioners, certified nurse midwives, and certified registered nurse anesthetists. It's also a valuable resource for anyone interested in understanding advanced pharmacology, including educators and professionals looking to refresh their knowledge or expand their understanding of pharmacotherapeutics.

History and Editions

The 6th edition of Pharmacotherapeutics for Advanced Practice Nurse Prescribers has been updated to reflect the most current standards of practice and evidence-based guidelines. This edition continues to focus on the medications and prescribing applications most relevant to advanced practice nurse prescribers, exploring diagnostic and treatment reasoning and rational drug selection. It’s the only text that meets all AACN/NONPF criteria, ensuring it remains a trusted resource in the field.

Author and Other Works

Teri Moser Woo, RN, PhD, ARNP, CPNP-PC, CNL, FAANP, and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAAN are the authors of Pharmacotherapeutics for Advanced Practice Nurse Prescribers. Teri Moser Woo is known for her expertise in pharmacotherapeutics and her ability to explain complex concepts clearly and simply. Wendy L. Wright brings her extensive experience in advanced practice nursing to the text, ensuring it remains current and relevant.

Key Features

• Comprehensive Coverage: The book provides in-depth information on pharmacologic principles and their applications in clinical practice.
• Interactive Learning Solution: The text is complemented by online case studies and Davis Edge online quizzing, which help students master advanced pharmacology content and prepare them for their roles as advanced practice nurse prescribers.
• Actionable Analytics: Actionable analytics enable instructors to monitor, track, and assess their students’ mastery of the content and their critical-thinking and decision-making skills.
• Updated Standards: The 6th edition reflects the most current standards of practice and evidence-based guidelines, making it a reliable resource for advanced practice nurse prescribers.

Detailed Information

ISBNs and Formats

• Hardcover: ISBN-13: 9781719648035
• eBook: Not available through the primary sources listed
• Rental Options: Available through various retailers

Publication Details

• Publisher: F.A. Davis Company
• Publication Date: April 16, 2024
• Number of Pages: 1456 pages
• Language: English

Other Editions and Formats

While there are no other editions or formats listed for this specific ISBN, it is worth noting that the book is available in new, used, and rental formats through various retailers.

Related ISBNs:

• 9781719651585 (Related ISBN for a potentially companion book or additional resource)

This detailed information section provides a quick reference for all the available formats and sources for Pharmacotherapeutics for Advanced Practice Nurse Prescribers, making it easier to find and access the book in the preferred format.

Table of Contents

I. THE FOUNDATION
1. The Role of the Nurse Practitioner as Prescriber
2. Review of the Basic Principles of Pharmacology
3. Rational Drug Selection
4. Legal and Professional Issues in Prescribing
5. Adverse Drug Reactions
6. An Introduction to Pharmacogenetics
7. Nutrition and Neutraceuticals
8. Herbal Therapies
9. Cannabis
10. Pharmacoeconomics
II. PHARMACOTHERAPEUTICS WITH SINGLE DRUGS
11. Drugs Affecting the Autonomic Nervous System
12. Drugs Affecting the Central Nervous System
13. Drugs Affecting the Cardiovascular and Renal Systems
14. Drugs Affecting the Respiratory System
15. Drugs Affecting the Hematological System
16. Drugs Affecting the Immune System: Immunizations
17. Drugs Affecting the Immune System: Immunomodulators
18. Drugs Affecting the Gastrointestinal System
19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs
20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs
21. Drugs Affecting the Reproductive System
22. Drugs Affecting the Bones and Joints
23. Drugs Affecting the Integumentary System
24. Drugs Used to Treat Bacterial Infections
25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections
26. Drugs Used to Treat Inflammatory Processes
27. Drugs Used to Treat Eye and Ear Disorders
III. PHARMACOTHERAPEUTICS WITH MULTIPLE DRUGS
28. Anemia
29. Anxiety and Depression
30. Attention Deficit Hyperactivity Disorder
31. Asthma and Allergy
32. Chronic Obstructive Pulmonary Disease
33. Contraception
34. COVID-19: Acute and Chronic
35. Dermatological Conditions
36. Diabetes Management
37. Gastroesophageal Reflux and Peptic Ulcer Disease
38. Headaches
39. Heart Failure
40. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome
41. Menopausal Hormone Therapy
42. Hyperlipidemia
43. Hypertension
44. Hyperthyroidism and Hypothyroidism
45. Obesity
46. Pain Management: Acute and Chronic Pain
47. Pneumonia
48. Sexually Transmitted Diseases and Vaginitis
49. Substance Use Disorder
50. Tuberculosis
51. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa
52. Urinary Tract Infection
IV. SPECIAL DRUG TREATMENT CONSIDERATIONS
1. Women as Patients
2. Men as Patients
3. Pediatric Patients
4. Transgendered Personas Patients
5. Geriatric Patients
Appendix A: New Drug Development